A Single-Center Experience Comparing Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning with Myeloablative Busulfan, Cyclophosphamide, and Antithymocyte Globulin for Chronic Granulomatous Disease
2016 ◽
Vol 22
(11)
◽
pp. 2011-2018
◽
2020 ◽
Vol 145
(2)
◽
pp. AB34
2018 ◽
Vol 54
(1)
◽
pp. 168-172
◽
2006 ◽
Vol 10
◽
pp. S1-S2
2012 ◽
Vol 88
(6)
◽
pp. 504-509
◽